Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
Clinical trial NCT01319240 · COMPLETED
Trial details
- NCT number
- NCT01319240
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2011-05-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.